New syringe acquisition and multi-person use of syringes among illegal drug users

Journal of Public Health Policy

Volumn 23, Issue 3, 2002, Pages 324-343

  Richard, Alan J ^a   Mosier, Victoria ^a   Atkinson, John S ^a  

^a Affiliated Systems Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DIAMORPHINE; ILLICIT DRUG; METHAMPHETAMINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INJECTION; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; SOCIAL DESIRABILITY; SYRINGE; UNITED STATES; VIRUS TRANSMISSION;

ADULT; EQUIPMENT CONTAMINATION; FEMALE; HIV INFECTIONS; HUMANS; MALE; NEEDLE SHARING; PHARMACIES; STREET DRUGS; SUBSTANCE ABUSE, INTRAVENOUS; SYRINGES; TEXAS;

EID: 0036053027     PISSN: 01975897     EISSN: 1745655X     Source Type: Journal    
DOI: 10.2307/3343228     Document Type: Article

References (67)

1. Centers for Disease Control and Prevention (CDC) (1998). HIV/AIDS Surveillance Report. US HIV and AIDS cases reported through December 31, 1998. Vol. 10, No. 2.
2. Cohen, H. M., Marmor, D., Des Jarlais, D., Spira, R., Friedman, S., and Yancovitz, S. Behavioral risk factors for HTLV-III/LAV seropositivity among intravenous drug users. 1985. Paper presented at the International Conference on AIDS, Atlanta, GA, April 1985.
3. Des Jarlais, D., and Friedman, S. Prevention policy questions for AIDS among intravenous drug users. Presented at the Annual Convention of the American Public Health Association. 1985. Washington, D.C., November 18.
4. Des Jarlais, D., Friedman, S., and Hopkins, W. “Risk Reduction for the Acquired Immunodeficiency Syndrome (AIDS) among Intravenous Drug Users,” Ann. Intern. Med. 103 (1985): 755-59.
5. Drotman, D. “Now Is the Time To Prevent AIDS, Am. J. Pub. Health 77 (2) (1987): 143.
6. Ginzburg, H. “Intravenous Drug Users and the Acquired Immunodeficiency Syndrome,” Public Health Rep. 99 (2) (1984): 206-12.
7. Ginzburg, H. S., Weiss, M., and Hubbard, R. “HTLV-III Exposure among Drug Users,” Cancer Res. 45 (1985): 4605-08.
8. Goldstein, P., French, J., Hunt, P., and Des Jarlais, D. Health Behavior and the Law: The Case of Dirty Needles. 1985. Presented to the American Society of Criminology. San Diego.
9. Koplan, J., Hardy, A., and Allen, J. “Epidemiology of Acquired Immunodeficiency Syndrome in Intravenous Drug Abusers,” J. Psychoactive Drugs 5 (1-2) (1985): 13-23.
10. Marmor, M., Des Jarlais, D., and Friedman, S. “The Epidemic of Acquired Immunodeficiency Syndrome (AIDS) and Suggestions for its Control in Drug Abusers,” J. Subst. Abuse Treat. 1 (1984): 237-47.
11. National Association of State Alcohol and Drug Abuse Directors. Aids and Drug Abuse. Alcohol and Drug Abuse Report. Washington, D.C.: July and August. 1986.
12. Nichols, N. The Mobilization Against AIDS—The Unfinished Story of a Virus. Cambridge, MA: Harvard University Press, 1986.
13. National Institute on Drug Abuse. International Experts Discuss Needle Sharing and AIDS. NIDA Notes. 2 (3) (1987).
14. Redfield, R., Markham, P., Salahuddin, S., Wright, D., Sargadharan, M., and Gallo, R. “Heterosexually Acquired HTLV-III/LAV Disease (AIDS Related Complex and AIDS): Epidemiologic Evidence for Female to Male Transmission,” J.A.M.A. 254 (1985): 2094-96.
15. Van de Perre, P., Clurneck, N., Carael, M., Nxabihimana, E., Robert-Guroff, M., Demoz, P., Freyens, P., Butzlei, J., Gallo, R. C., and Kan-yamupira, J. “Female Prostitutes: A Risk Group for Infection with Human T-cell Lymphocyte Virus Type III,” Lancet 8454 (1985): 524-26.
16. Watters, J., Iura, D., and Iura, K. AIDS Prevention and Education Services to Intravenous Drug Users through the Mid-city Consortium to Combat AIDS: Administrative Report on the First Six Months. Research Activity Memorandum. Department of Alcohol and Drug Problems, State of California. 6 (i) (1987).
17. Weibel, W. “Combining Ethnographic and Epidemiologic Methods in Targeted AIDS Interventions: The Chicago Mode. Needle Sharing among Intravenous Drug Abusers: National and International Perspectives,” Bethesda, MD: NIDA Res. Monogr. 80 (1987).
18. Winkelstein, W., Samuel, M., and Padian, N. S. “Potential Transmission of AIDS-Associated Retrovirus from Bisexual Men in San Francisco to their Female Sexual Contacts,” J.A.M.A. 255(7) (1986): 901.
19. Watters, J. K. “Trends in Risk Behavior and HIV Seroprevalence in Heterosexual Injection Drug Users in San Francisco, 1986-1992. J.A.I.D.S. 7 (12) (1994): 1276-81.
20. Watters, J. K. “Meaning and Context: The Social Facts of Intravenous Drug Use and HIV Transmission in the Inner City,” J. Psychoactive Drugs. 20 (2) (1988): 173-77.
21. Friedman, S. R., Chapman, T. F., Perlis, T. E., et al. “Similarities and Differences by Race/Ethnicity in Changes of HIV Seroprevalence and Related Behaviors among Drug Injectors in New York City, 1991-1996. J.A.I.D.S. 22 (1) (1999): 83-91.
22. Friedman, S. R., Des Jarlais, D. C., and Sterk, C. E. “AIDS and the Social Relations of Intravenous Drug Users,” The Milbank Quarterly. 68 (Suppl. 1) (1990): 85-110.
23. 5 Social and Risk Networks for Understanding and Preventing HIV Infection,” Soc. Sci. Med. 38 (1) (1994): 67-78.
24. Fullilove, R. E., Fullilove, M. T., Bowser, B., and Gross, S. “Crack users: The New AIDS Risk Group,” Cancer Detect. Prev. 14 (3) (1990a): 363-68.
25. Fullilove, R. E., Fullilove, M. T., Bowser, B., and Gross, S. “Risk of Sexually Transmitted Disease among Black Adolescent Crack Users in Oakland and San Francisco, California,” J.A.M.A. 263 (6) (1990b): 851-55.
26. Hahn, R. A., Magder, L. S., Aral, S. O., Johnson, R. E., and Larsen, S. A. “Prevalence of HIV Infection among Intravenous Drug Users in the United States,” J.A.M.A. 261 (18) (1989): 2677-84.
27. Friedman, S. R., Curtis, R., Neaigus, A., Jose, B., and Des Jarlais, D.C. Social Networks, Drug Injectors, Lives, and HIV/AIDS. New York: Kluwer Academic/Plenum, 1999.
28. Huebert, K., and James, D. “High Risk Behaviors for Transmission of HIV among Clients in Treatment for Substance Abuse,” J. Drug Issues. 22 (4) (1992): 885-901.
29. Des Jarlais, D. C., Marmor, M., and Paone, D. “HIV Incidence among Injecting Drug Users in New York City Syringe-exchange Programmes,” Lancet. 348 (9033) (1996): 987-91.
30. Groseclose, S. L., Weinstein, B., Jones, T. S., Valleroy, L. A., and Kassler, W. J. “Impact of Increased Legal Access to Needles and Syringes on Practices of Injecting-drug Users and Police Officers—Connecticut, 1992-1993,” JA.I.D.S. 10 (1995) 82-96.
31. Gleghorn, A. A., Jones, T. S., Doherty, M., et al. “Acquisition and Use of Needles and Syringes by Injecting Drug Users in Baltimore, Maryland,” J.A.I.D.S. 10 (1995): 97-103.
32. Gleghorn, A. A., Jones, T. S., Doherty, M. C., Celentano, D. D., and Vla-hov, D. “Acquisition and Use of Needles and Syringes by Injecting Drug Users in Baltimore, Maryland,” J.A.I.D.S. 10 (1) (1995): 97-103.
33. Nelson, K. E., Vlahov, D., Cohn, S., et al. “Human Immunodeficiency Virus Infection in Diabetic Intravenous Drug Users,” J.A.M.A. 266 (1991): 2259-61.
34. Valleroy, L. A., Weinstein, B., Jones, T. S., Groseclose, S. L., Rolfs, R.T., and Kassler, W. J. “Impact of Increased Legal Access to Needles and Sringes on Community Pharmacies’ Needle and Syringe Sales—Connecticut, 1992-1993 [see comments],” J.A.I.D.S. 10 (1) (1995): 73-81.
35. Gostin, L. O., and Lazzarini, Z. “Prevention of HIV/AIDS among Injection Drug Users: The Theory and Science of Public Health and Criminal Justice Approaches to Disease Prevention,” Emory Law Journal. 46 (1997): 587-696.
36. Veal, G. R. “The Model Drug Paraphernalia Act: Can We Outlaw Head Shops—and Should We? Georgia Law Review,” 16 (1981): 137-39.
37. Bluthenthal, R. N., Krai, A. H., Erringer, E. A., and Edlin, B. R. “Drug Paraphernalia Law and Injection-Related Infectious Disease Risk Among Injectors,” J. Drug Issues. 29 (1) (1999): 1-16.
38. Compton, W. M., Cottier, L. B., Decker, S. H., et al. “Legal Needle Buying in St. Louis,” Am.]. Public Health. 82 (1992): 595-96.
39. Day, D. The Injection-related AIDS Epidemic in the United States: States and Metro Areas with the Highest Rates. Report from the Dogwood Center, November 1999. Available online: http://www.dogwoodcen-ter. orgltoplnarrative.html. 1999.
40. Camacho, L. M., Brown, B. S., and Simpson, D. D. “Psychological dysfunction and HIV/AIDS Risk Behavior,” J.A.I.D.S. 11 (2) (1996): 198-202.
41. Des Jarlais, D. C., Friedman, S. R., and Strug, D. “AIDS and Needle Sharing within the IV-drug Use Subculture,” in: Seldman, D., Johnson, T., editors. The Social Dimensions of AIDS. New York: Praeger Press. 1986; m-25.
42. Stryker, J. “IV Drug Use and AIDS: Public Policy and Dirty Needless,” J. Health Polit. Policy Law. 14 (4) (1989): 719-40.
43. Murphy, S. “Intravenous Drug Use and AIDS: Notes on the Social Economy of Needle Sharing,” Contemp. DrugProb. 14 (1987): 373-95.
44. Coleman, R. M., and Curtis, D. “Distribution of Risk Behaviors for HIV Infection Amongst Intravenous Drug Users,” Br. J. Addict. 83 (1988a): 1331-34.
45. Coleman R. M., Curtis, D., and Feinmann, C. “Perception of risk of HIV Infection by Injecting Drug Users and Effects on Medical Clinical Attendance,” Br. J. Addict. 83 (1988b): 1325-29.
46. Schoenbaum, E. E., Hartel, D., Selwyn, P. A., et al. “Risk Factors for Human Immunodeficiency Virus Infection in Intravenous Drug Users,” N. Engl. J. Med. 321 (13) (1989): 874-79.
47. Booth, R. “Predictors of Unsafe Needle Practices: Injection Drug Users in Denver” J.A.I.D.S. 7 (1994): 504-08.
48. Woods, W. J., Abramowitz, A., Guydish, J., Clark, W., Hearst, N., and Kiefer, R. Fifth International Conference on AIDS. Montreal, Canada (abstract WDP 74), 1989.
49. Dolan, M. P., Black, J. L., Deford, H. A., Skinner, J. R., and Robinwitz, R. Public Health Rep. 102 (4) (1989): 395-98.
50. Donoghoe, M. C., Dolan, K. A., and Stimson, G. V. “Life-style Factors and Social Circumstances of Syringe Sharing in Injecting Drug Users,” Br. J. Addict. 87 (1992): 993-1003.
51. Wallace, B. C. “Relapse Prevention in Psychoeducational Groups for Compulsive Crack Cocaine Smokers,” J. Subst. Abuse Treat. 6 (1989): 229-39.
52. Donoghoe, M. C., Stimson, G. V., and Dolan, K. “Sexual Behavior of Injecting Drug Users and Associated Risks of HIV Infection for Non-injecting Sexual Partners,” AIDS Care 1 (1988): 55-58.
53. Holmberg, S. “The Estimated Prevalence and Incidence of HIV in 96 large US Metropolitan Areas,” Am.]. Public Health. 86 (1996): 642-54.
54. Centers for Disease Control and Prevention (CDC). HIV/AIDS Surveillance Report. US HIV and AIDS cases reported through June 1999. 11 (1) (1999)
55. TX. Health and Safety Code 481.125 (1989).
56. Bell, D. C., Heath, V., Patek, J., and Atkinson, J. A. A social network view of drug use. Unpublished manuscript. (2000).
57. Bell, D. C., and Trevino, R. A. “Modeling HIV, Risk,” J.A.I.D.S. 22 (1999): 280-87.
58. Klovdahl, A. S. “Urban Social Networks: Some Methodological Problems and Possibilities,” in: Kochen M., editor. The Small World. New Jersey: Ablex Publishing Corporation, 1989: 176-210.
59. Liebow, E., Mc Grady, G., Branch, K., et al. “Eliciting Social Network Data and Ecological Model-building: Focus on Choice of Name Generators and Administration of Random-walk Study Procedures,” Soc. Net. 17 (1995): 2.57-72.
60. Broadhead, R. S., Heckathorn, D. D., Grund, J.P.C., Stern, L. S., and Anthony, D. L. “Drug Users Versus Outreach Workers in Combating AIDS: Preliminary Results of a Peer-driven Intervention,” J. Drug Issues. 2-5 (3) (1995): 531-4
61. Heckathorn, D. D. “Respondent-driven Sampling: A New Approach to the Study of Hidden Populations,” Soc. Prob. 44 (2) (1997): 174-99.
62. Derogatis, L. BSI-brief Symptom Inventory: Administration, Scoring and Procedures Manual. Minneapolis: National Computer Systems, 1993.
63. Simpson, D. D. TCU/DATAR Forms Manual: Drug Abuse Treatment for AIDS Risk Reduction (DATAR). Fort Worth: Institute for Behavioral Research. 1992.
64. Crowne, D. P., and Marlowe, D. “A New Scale of Social Desirability Independent of Psychopathology,” J. Consult. Clin. Psychol. 24 (1960): 349-54
65. Reynolds, H. Analysis of Nominal Data. London: Sage, 1977.
66. Menard, J. Applied Logistic Regression. New York: Sage, 1995.
67. Agresti, A. Introduction to Categorical Data Analysis. New York: Wiley &Sons, 1996.